These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17215128)

  • 21. Synthesis and characterization of the novel fluorescent prolyl oligopeptidase inhibitor 4-fluoresceinthiocarbamoyl-6-aminocaproyl-L-prolyl-2(S)-(hydroxyacetyl)pyrrolidine.
    Venäläinen JI; Wallén EA; Poso A; García-Horsman JA; Männistö PT
    J Med Chem; 2005 Nov; 48(23):7093-5. PubMed ID: 16279765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of prolyl endopeptidase inhibitors and evaluation of their structure-activity relationships: in vitro inhibition of prolyl endopeptidase from canine brain.
    Arai H; Nishioka H; Niwa S; Yamanaka T; Tanaka Y; Yoshinaga K; Kobayashi N; Miura N; Ikeda Y
    Chem Pharm Bull (Tokyo); 1993 Sep; 41(9):1583-8. PubMed ID: 8221972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereoselective synthesis of constrained azacyclic hydroxyethylene isosteres as aspartic protease inhibitors: dipolar cycloaddition and related methodologies toward branched pyrrolidine and pyrrolidinone carboxylic acids.
    Hanessian S; Yun H; Hou Y; Tintelnot-Blomley M
    J Org Chem; 2005 Aug; 70(17):6746-56. PubMed ID: 16095294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification by 19F NMR of traditional Chinese medicinal plants possessing prolyl oligopeptidase inhibitory activity.
    Tarragó T; Frutos S; Rodriguez-Mias RA; Giralt E
    Chembiochem; 2006 May; 7(5):827-33. PubMed ID: 16628753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of prolyl oligopeptidase by Fmoc-aminoacylpyrrolidine-2-nitriles.
    Li J; Wilk E; Wilk S
    J Neurochem; 1996 May; 66(5):2105-12. PubMed ID: 8780042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue.
    Fülöp V; Szeltner Z; Renner V; Polgár L
    J Biol Chem; 2001 Jan; 276(2):1262-6. PubMed ID: 11031266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.
    Borthwick AD; Exall AM; Haley TM; Jackson DL; Mason AM; Weingarten GG
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1719-22. PubMed ID: 12067545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and herbicidal evaluation of novel 3-[(alpha-hydroxy-substituted)benzylidene]pyrrolidine-2,4-diones.
    Zhu Y; Zou X; Hu F; Yao C; Liu B; Yang H
    J Agric Food Chem; 2005 Nov; 53(24):9566-70. PubMed ID: 16302778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary chemico-biological studies on Ru(III) compounds with S-methyl pyrrolidine/dimethyl dithiocarbamate.
    Giovagnini L; Mancinetti E; Ronconi L; Sitran S; Marchiò L; Castagliuolo I; Brun P; Trevisan A; Fregona D
    J Inorg Biochem; 2009 May; 103(5):774-82. PubMed ID: 19250682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poststatin, a new inhibitor of prolyl endopeptidase. VI. Endopeptidase inhibitory activity of poststatin analogues containing pyrrolidine ring.
    Tsuda M; Muraoka Y; Someno T; Nagai M; Aoyagi T; Takeuchi T
    J Antibiot (Tokyo); 1996 Sep; 49(9):900-8. PubMed ID: 8931724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
    Cheng XC; Wang Q; Fang H; Tang W; Xu WF
    Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors.
    Shi Y; Sitkoff D; Zhang J; Han W; Hu Z; Stein PD; Wang Y; Kennedy LJ; O'Connor SP; Ahmad S; Liu EC; Seiler SM; Lam PY; Robl JA; Macor JE; Atwal KS; Zahler R
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5952-8. PubMed ID: 17855089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives.
    Portevin B; Benoist A; Rémond G; Hervé Y; Vincent M; Lepagnol J; De Nanteuil G
    J Med Chem; 1996 Jun; 39(12):2379-91. PubMed ID: 8691432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and inhibitory activity of acyl-peptidyl-pyrrolidine derivatives toward post-proline cleaving enzyme; a study of subsite specificity.
    Saito M; Hashimoto M; Kawaguchi N; Shibata H; Fukami H; Tanaka T; Higuchi N
    J Enzyme Inhib; 1991; 5(1):51-75. PubMed ID: 1669438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy.
    Van der Veken P; Fülöp V; Rea D; Gerard M; Van Elzen R; Joossens J; Cheng JD; Baekelandt V; De Meester I; Lambeir AM; Augustyns K
    J Med Chem; 2012 Nov; 55(22):9856-67. PubMed ID: 23121075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure activity relationship of inhibitors specific for prolyl endopeptidase.
    Yoshimoto T; Tsuru D; Yamamoto N; Ikezawa R; Furukawa S
    Agric Biol Chem; 1991 Jan; 55(1):37-43. PubMed ID: 1368673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase.
    Gorrão SS; Hemerly JP; Lima AR; Melo RL; Szeltner Z; Polgár L; Juliano MA; Juliano L
    Peptides; 2007 Nov; 28(11):2146-54. PubMed ID: 17904692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase.
    Jain RP; Vederas JC
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3655-8. PubMed ID: 15203137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.